68Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma: A Head-to-Head Comparison With 18F-FDG : Clinical Nuclear Medicine

Secondary Logo

Journal Logo

Interesting Images

68Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma

A Head-to-Head Comparison With 18F-FDG

Chopra, Sejal MSc; Walia, Rama MD; Mathur, Yamini MD, DNB; Roesch, Frank PhD; Moon, Euy Sung PhD; Rana, Nivedita PhD; Pandey, Somit MSc; Chatterji, Debajyoti DM§; Kumar, Rajender MD; Singh, Harmandeep MD; Mittal, Bhagwant Rai MD, DNB; Shukla, Jaya PhD

Author Information
Clinical Nuclear Medicine 48(4):p e173-e175, April 2023. | DOI: 10.1097/RLU.0000000000004563

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid